Abstract
Single-Agent Ibrutinib Versus Real-World Treatments for Patients with Treatment-Naïve Chronic Lymphocytic Leukemia: Adjusted Comparison of Resonate-2™ with Real-World Databases
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have